Sterotherapeutics Begins Phase 2 Trial for Cushing`s Syndrome
24 Feb 2025 //
PR NEWSWIRE
Sterotherapeutics Signs Licensing Agreement Aimed to Improve Multiple Myeloma
30 Mar 2022 //
PRNEWSWIRE
24 Feb 2025 //
PR NEWSWIRE
30 Mar 2022 //
PRNEWSWIRE